AstraZeneca Pharma Q3 net up 84 pc to Rs 16 crore
Delhi : Drug firm AstraZeneca Pharma reported an 84.08 per cent increase in its standalone net profit at Rs 15.96 crore for the third quarter ended December.
The company had reported a net profit of Rs 8.67 crore in October-December quarter a year ago, AstraZeneca Pharma said in a BSE filing.
Its total income from operations was up 3.94 per cent to Rs 150.28 crore during the quarter under review as against Rs 144.58 crore earlier.
AstraZeneca's overall expenses were up 1.44 per cent to Rs 139.36 crore as against Rs 137.38 crore in the corresponding period of last fiscal.
Shares of AstraZeneca settled at Rs 948.70 on BSE, up 1.02 per cent from the previous close.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd